HC Andersen Capital Events 25/4: Meet the management in ExpreS2ion Biotechnologies and NeoDynamics
HC Andersen Capital is today hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Expres2ion Biotechnologies - Rights IssueExpres2ion Biotechnologies have announced a new share issue with preferential rights for the Company’s existing shareholders. The Rights Issue is fully covered by subscription undertakings. The gross proceeds of approximately SEK 73 million will primarily be used as to advance the breast cancer vaccine candidate ES2B-C001 to completion of the preclinical safety studies, advance other pipeline